In recent years, the range on offer in the freezer has changed considerably. Where the classic beef burger used to dominate, there are now alternatives made from pea protein, insects or even the meat-like mixture from Beyond Meat. But who is actually benefiting from this trend?
The market for weight-loss drugs is booming. Not only the pharmaceutical companies offering the medication are benefiting, but also their suppliers. Among them are the Swiss companies Bachem and Ypsomed.
Luxury seeks to sell exclusivity. At the same time, the industry wants to harness the purchasing power of the masses.
Global equity markets are plunging. In this environment, products with defensive features are in favour.
After a period of weakness, Roche shares are making a comeback. This makes the pharmaceutical giant the most valuable Swiss company, pushing Nestlé into second place.
Two years ago, everyone was talking about the Metaverse. But who is talking about the Metaverse today? Artificial intelligence is the number one topic of conversation. But is the Metaverse really dead, or is it a long-term trend that we'll be hearing about again soon?
US equity markets are dominated by a handful of technology companies. In the upcoming earnings season, they will once again be the centre of attention, as the expectations for Wall Street's stars are high.
The outlook for gold miners seems bright given the high price of gold. But it is not just the precious metal that is expensive; the gold industry's production costs have also recently hit record highs.
«When I was your age, television was called books.» – William Goldman
The need for entertainment is a constant, yet the forms in which it is consumed are changing and evolving. What does the entertainment landscape look like these days, and how do Netflix and Disney secure their share of our time?
The Swiss equity market has experienced a positive first half-year. This is reflected in the SMI, which has risen significantly since the beginning of the year. However, the performance of individual stocks varies considerably.
19.313% p.a. ZKB Barrier Reverse Convertible, 10.01.2025 on worst of LOGN SE/AMS SE 135804789 / CH1358047897 |
ZKB Barrier Reverse Convertible on worst of CrowdStrike Holdings Inc/Snowflake Inc 132911907 / CH1329119072 |
15.6282% p.a. ZKB Barrier Reverse Convertible, 19.02.2025 auf AMS SE 132914049 / CH1329140490 |
16.0994% p.a. ZKB Barrier Reverse Convertible, 19.02.2025 auf AMS SE 135803773 / CH1358037732 |
48.21% p.a. ZKB Barrier Reverse Convertible mit bedingtem Coupon, 29.11.2024 on worst of AMS SE/TEMN... 121488823 / CH1214888237 |